JP2002543090A - インターフェロンα２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー - Google Patents

インターフェロンα２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー

Info

Publication number
JP2002543090A
JP2002543090A JP2000614285A JP2000614285A JP2002543090A JP 2002543090 A JP2002543090 A JP 2002543090A JP 2000614285 A JP2000614285 A JP 2000614285A JP 2000614285 A JP2000614285 A JP 2000614285A JP 2002543090 A JP2002543090 A JP 2002543090A
Authority
JP
Japan
Prior art keywords
homodimer
monomer
heterodimer
interferon
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000614285A
Other languages
English (en)
Japanese (ja)
Inventor
ヴィーザー，ライムント，ヨット．
Original Assignee
ヴィーザー，ライムント，ヨット．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴィーザー，ライムント，ヨット． filed Critical ヴィーザー，ライムント，ヨット．
Publication of JP2002543090A publication Critical patent/JP2002543090A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000614285A 1999-04-27 2000-04-19 インターフェロンα２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー Pending JP2002543090A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19919149.2 1999-04-27
DE19919149A DE19919149A1 (de) 1999-04-27 1999-04-27 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
PCT/DE2000/001234 WO2000064936A2 (de) 1999-04-27 2000-04-19 VON INTERFERON α2 ABGELEITETE PEPTID-HOMODIMERE UND PEPTID-HETERODIMERE

Publications (1)

Publication Number Publication Date
JP2002543090A true JP2002543090A (ja) 2002-12-17

Family

ID=7906048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000614285A Pending JP2002543090A (ja) 1999-04-27 2000-04-19 インターフェロンα２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー

Country Status (6)

Country Link
EP (1) EP1171463A2 (de)
JP (1) JP2002543090A (de)
AU (1) AU5388100A (de)
CA (1) CA2371662A1 (de)
DE (1) DE19919149A1 (de)
WO (1) WO2000064936A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005291741B2 (en) 2004-10-07 2011-11-24 Universitat Zurich Type I interferon blocking agents for prevention and treatment of psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1991003251A1 (en) * 1989-09-08 1991-03-21 California Institute Of Biological Research Cr2 ligand compositions and methods for modulating immune cell functions
US5684129A (en) * 1992-07-07 1997-11-04 Fish; Eleanor N. Interferon receptor binding peptides

Also Published As

Publication number Publication date
WO2000064936A2 (de) 2000-11-02
AU5388100A (en) 2000-11-10
DE19919149A1 (de) 2000-11-16
EP1171463A2 (de) 2002-01-16
WO2000064936A3 (de) 2001-02-22
CA2371662A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
US7736638B2 (en) Interleukin-15 antagonist peptide
CA1265649A (en) Peptide antibodies and their use in detecting oncogene products
CA1257540A (en) Peptide antibodies and their use in detecting oncogene products
US4857637A (en) Methods and compositions for immunologically modulating growth hormone receptor activity
JP2022106976A (ja) 操作された抗体化合物およびこれらの抱合体
US8450068B2 (en) IgE antibodies to chimeric or humanized IgG therapeutic monoclonal antibodies as a screening test for anaphylaxis
US6699973B1 (en) Antibodies to peptides that target GIT receptors and related methods
JPS60500716A (ja) ウイルス腫瘍遺伝子からの合成ポリペプチド
EP0177814A2 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
EP0369816A2 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
US5196319A (en) Primary biliary cirrhosis autoantigen
JP2958118B2 (ja) 腫瘍放出粒子（ｔｌｐ）複合体の抗原性領域とそれらに対する抗体
US9884918B2 (en) HER2DELTA16 peptides
Johnson et al. Identification of an antigenic epitope and receptor binding domain of human C5a.
JP2002543090A (ja) インターフェロンα２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー
JP2002543091A (ja) インターロイキン１２に由来するペプチドホモダイマーおよびペプチドヘテロダイマー
JP2717319B2 (ja) Ｒ―ｉｆｎ―ベータエピトープ部位を代表するペプチド、それに対する抗体、およびその用途
JPS63264600A (ja) ウシ白血病ウイルスに対する感染防御抗体を誘導するペプチド分画と、この分画を得る方法と、この分画の遺伝暗号配列と、この分画から製造されるワクチン
KR900008014B1 (ko) 펩타이드 항체의 제조방법
US6387875B1 (en) Method of use for murine leukaemia inhibitory factor-binding protein (mLBP)
WO1991003251A1 (en) Cr2 ligand compositions and methods for modulating immune cell functions
JP3025002B2 (ja) Ｄｎａ、ポリペプチド、抗体、およびそれらの用途
JPH06125784A (ja) モノクローナル抗体，ハイブリドーマ，その製造法および用途
JP3024987B2 (ja) 抗体、その製造法および用途
JPH10114680A (ja) 制癌剤